Tokyo Tape
Sign in
← Immuno-Biological Laboratories

Quarterly report · Q1

4570.TEDINET S100OZBI
Period2022-04-01 → 2022-06-30
Filed2022-08-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥156m2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥648m2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥125m2021-04-01 → 2021-06-30Cons.Net sales
Operating income−¥15m2022-04-01 → 2022-06-30Cons.Operating income
Operating income−¥74m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income−¥55m2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income−¥243m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥102m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax−¥57m2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax−¥109m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)−¥59m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥259m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥111m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income−¥59m2022-04-01 → 2022-06-30Cons.Profit loss
Net income−¥111m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥1.6bnat 2022-06-30Cons.Assets
Total assets¥1.7bnat 2022-03-31Cons.Assets
Total assets¥1.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥340mat 2022-06-30Cons.Liabilities
Total liabilities¥337mat 2022-03-31Cons.Liabilities
Net assets / equity¥1.3bnat 2022-06-30Cons.Net assets
Net assets / equity¥1.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥1.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥463mat 2022-06-30Cons.Cash and deposits
Cash and deposits¥508mat 2022-03-31Cons.Cash and deposits
EPS (basic)¥-6.322022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-27.782021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-11.892021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio79.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio80.2%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio88.8%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 25
SegmentItemPeriodValue
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentrevenue2022-04-01 → 2022-06-30¥829,000
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentrevenue external2022-04-01 → 2022-06-30¥829,000
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentsegment profit2022-04-01 → 2022-06-30−¥5m
jpcrp040300-q1r_E00986-000Gene Recombination Silkworm Developmentreportable segmentsegment profit2022-04-01 → 2022-06-30−¥19m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥156m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥156m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥9m
—segment totalrevenue2022-04-01 → 2022-06-30¥156m
—segment totalrevenue external2022-04-01 → 2022-06-30¥156m
—segment totalsegment profit2022-04-01 → 2022-06-30−¥15m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥2m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥2m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30¥240,000
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentrevenue2021-04-01 → 2021-06-30¥2m
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentrevenue external2021-04-01 → 2021-06-30¥2m
jpcrp040300-q1r_E00986-000Cosmeticsreportable segmentsegment profit2021-04-01 → 2021-06-30−¥4m
jpcrp040300-q1r_E00986-000Gene Recombination Silkworm Developmentreportable segmentsegment profit2021-04-01 → 2021-06-30−¥29m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentrevenue2021-04-01 → 2021-06-30¥125m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentrevenue external2021-04-01 → 2021-06-30¥123m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥2m
jpcrp040300-q1r_E00986-000Immunity Relatedreportable segmentsegment profit2021-04-01 → 2021-06-30−¥41m
—segment totalrevenue2021-04-01 → 2021-06-30¥127m
—segment totalrevenue external2021-04-01 → 2021-06-30¥125m
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥2m
—segment totalsegment profit2021-04-01 → 2021-06-30−¥74m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 307
ItemContextValueUnit
Impairment loss elPrior1YTDDuration7041000JPY
Impairment loss elCurrentYTDDuration804000JPY
Extraordinary lossPrior1YTDDuration7041000JPY
Extraordinary lossCurrentYTDDuration1913000JPY
Income before income taxesPrior1YTDDuration-108681000JPY
Income before income taxesCurrentYTDDuration-56644000JPY
Income taxes currentPrior1YTDDuration2058000JPY
Income taxes currentCurrentYTDDuration2292000JPY
Income taxesPrior1YTDDuration2058000JPY
Income taxesCurrentYTDDuration2292000JPY
Profit lossPrior1YTDDuration-110740000JPY
Profit lossCurrentYTDDuration-58937000JPY
Profit loss attributable to owners of parentPrior1YTDDuration-110740000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-58937000JPY
Profit lossPrior1YTDDuration-110740000JPY
Profit lossCurrentYTDDuration-58937000JPY
Comprehensive incomePrior1YTDDuration-110740000JPY
Comprehensive incomeCurrentYTDDuration-58937000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration-110740000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-58937000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration－JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration－JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00986-000ImmunityRelatedReportableSegmentMember123275000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00986-000GeneRecombinationSilkwormDevelopmentReportableSegmentMember－JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E00986-000CosmeticsReportableSegmentsMember1875000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember125150000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration125150000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00986-000ImmunityRelatedReportableSegmentMember1689000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00986-000GeneRecombinationSilkwormDevelopmentReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E00986-000CosmeticsReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember1689000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-1689000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00986-000ImmunityRelatedReportableSegmentMember124964000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00986-000GeneRecombinationSilkwormDevelopmentReportableSegmentMember－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00986-000CosmeticsReportableSegmentsMember1875000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember126840000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-1689000JPY
Net salesPrior1YTDDuration125150000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00986-000ImmunityRelatedReportableSegmentMember-41224000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00986-000GeneRecombinationSilkwormDevelopmentReportableSegmentMember-29111000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00986-000CosmeticsReportableSegmentsMember-3796000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember-74133000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember240000JPY
Operating incomePrior1YTDDuration-73893000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00986-000ImmunityRelatedReportableSegmentMember155627000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00986-000GeneRecombinationSilkwormDevelopmentReportableSegmentMember－JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00986-000CosmeticsReportableSegmentsMember829000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember156456000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass